INTRODUCTION AND OBJECTIVES: In 2012, the USPSTF recommended against prostate specific antigen (PSA)-based PCa screening in all men, regardless of age and/or race. Initial reports showed a substantial drop in PSA screening in response to these recommendations, which was mainly evident in younger patients (aged <75 years old). Our objective was to determine if the downward trend continued past the immediate response to the recommendation, and if it varied by age and race.
INTRODUCTION AND OBJECTIVES: In 2012, the USPSTF recommended against prostate specific antigen (PSA)-based PCa screening in all men, regardless of age and/or race. Initial reports showed a substantial drop in PSA screening in response to these recommendations, which was mainly evident in younger patients (aged <75 years old). Our objective was to determine if the downward trend continued past the immediate response to the recommendation, and if it varied by age and race.
METHODS: We evaluated a total of 17,554 men aged 50 years or older, who were interviewed by the National Health Interview Survey 2010 Survey , 2013 Survey , and 2015 . PSA screening was defined as men undergoing PSA testing in the past 12 months preceding survey year for reasons other than prostate cancer/disease. Prevalence of PSA screening per survey year was assessed in the entire cohort, and after stratifying according to age and race. Multivariate logistic regression model calculated the odds of receiving PSA screening in 2013 and 2015 compared to 2010. Interaction analysis were performed using age and race, to examine if these variables modify the effect of survey year on the odds of PSA screening. CONCLUSIONS: Our findings show that the initial significant drop (4.6%) in PSA screening, which occurred in the first year following the 2012 USPSTF recommendation, was not maintained in the subsequent years (drop of 0.4% only). This might be, at least partially, attributed to the controversy regarding the validity of these recommendations. Conversely to previous report, age does not seem to have an impact on the changes in PSA screening. Likewise, PSA screening seems to drop equally in White and Black men. This last finding might be worrisome, given that the 2012 USPSTF recommendations were mainly based on the PLCO trial, in which only 4% of the population was Black. 
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INTRODUCTION AND OBJECTIVES:
The 2012 USPSTF recommendation against screening for prostate cancer has impacted rates of PSA screening and appears to be associated with declining prostate cancer incidence. Our objective was to examine a large, national claims-based database to characterize health care utilization that may explain these trends. We evaluate rates of PSA testing, prostate biopsy, prostate cancer detection, and treatment in the years surrounding the USPSTF recommendation.
METHODS: MarketScan (which captures > 30 million privately insured patients in the United States) claims were queried for all men age 40-64 years between 2008-2013. The at-risk population consisted of men without a diagnosis of prostate cancer. PSA testing, prostate biopsy, prostate cancer diagnosis and treatment were determined using ICD-9 and CPT codes. Prostate cancer cases were defined as men who underwent prostate biopsy and then had 2 encounters within 6 months with a prostate cancer diagnosis. Treatments ascertained included treatments for curative intent of localized prostate cancer (i.e., radical prostatectomy, external beam radiation, brachytherapy) and systemic treatments.
RESULTS: There were 5.27 -6.79 million qualifying men in MarketScan each year. PSA testing, prostate biopsy, and prostate cancer detection declined significantly from 2009 to 2013 ( Figure) , most notably between 2011 and 2012. Prostate biopsy rate per 100 patients with a PSA test decreased from 2.31 to 1.85 (p < 0.01). Prostate cancer incidence per prostate biopsy increased from 0.356 to 0.380 (p < 0.01). Treatment for localized prostate cancer decreased from 2009 to 2013 from 154 per 100,000 men to 112 per 100,000 men (p < 0.01). Over the same study period, systemic treatment also decreased from 5.64 per 100,000 men to 4.70 per 100,000 men, p < 0.01). Of new prostate cancer diagnoses, the proportion managed with treatment for curative intent decreased from 67% to 60% (p < 0.01).
CONCLUSIONS: PSA testing, prostate biopsy, prostate cancer incidence, and treatment for prostate cancer decreased in the years surrounding the USPSTF recommendation against prostate cancer screening. The changes in incidence following the USPSTF statement may be driven by different practice patterns around PSA-based referral and prostate biopsy. Heather Di Carlo*, Aylin Tekes, John Gearhart, Baltimore, MD INTRODUCTION AND OBJECTIVES: Radical dissection of the urogenital fibers and the thickened smooth and striated muscle fibers connecting the posterior urethra and bladder plate to the diastatic pubic rami is crucial for adequate placement of the posterior vesicourethral unit deep within the pelvis during classic bladder exstrophy (CBE) and cloacal exstrophy (CE) closure, as well as ensuring successful outcomes. Intraoperative magnetic resonance imaging (MRI) guided navigation of the pelvic floor offers a novel technique for identification of the urogenital diaphragm fibers and the thickened muscular attachments between the posterior urethra, bladder plate and pubic rami during CBE closure.
METHODS: Institutional review board and Food and Drug Administration approval was obtained for use of Brainlabâ (Munich, Germany) intraoperative MRI-guided navigation of the pelvic floor anatomy during closure of CBE at the authors' institution. Pre-operative pelvic MRI was obtained one day prior to exstrophy closure in patients necessitating pelvic osteotomies. Intraoperative registration was performed after pre-operative planning with a pediatric radiologist utilizing five anatomic landmarks immediately prior to initiation of surgery. Accuracy of identification of pelvic anatomy was assessed by three pediatric urologic surgeons and one pediatric radiologist.
RESULTS: 32 patients with CBE and 2 patients with CE closed at the authors' institution have successfully utilized Brainlabâ technology to navigate and guide the dissection of the pelvic floor intraoperatively. All patients had 100% accuracy in correlation of gross anatomic landmarks with MRI identified landmarks intraoperatively, and all have had successful closure without any complication.
CONCLUSIONS: Brainlabâ intraoperative MRI-guided pelvic floor navigation and dissection is an effective way to accurately identify pelvic anatomy during CBE and CE closure. Future assessment of realtime changes in pelvic floor anatomy comparing pre-closure to postclosure MRI will allow quantification of pelvic floor anatomy in these patients and may allow for intra-institutional telementoring in this most important first step of exstrophy reconstruction.
Source of Funding: none
V7-02 ROBOTIC ASSISTED ILEOVESICOSTOMY & CECOSTOMY TUBE
Christina Ching, Molly Fuchs*, Christopher Brown, Daniel DaJusta, Columbus, OH INTRODUCTION AND OBJECTIVES: Robotic surgical techniques have been adopted for procedures in pediatric urology but reconstruction for neurogenic bladder has been an area where it is underutilized. The reasons for this may include the need to create a bowel anastomosis, relative inexperience with robotics or perceived limitations of the technology. Our objective is to demonstrate the successful use of robotics in creating an ileovesicostomy incontinent urinary diversion with a complete intra corporeal bowel anastomosis and cecostomy tube placement.
METHODS: A 15 year-old female with myelomeningocele and neurogenic bladder had multiple failed attempts at compliance with clean intermittent catheterization program. She developed acute kidney injury and it was recommended that she undergo incontinent urinary diversion. We utilized the Intuitive Surgical DaVinciâ Si robotic surgery system for the operation. Prior to port placement, we performed cystoscopy and injected 300 units of botox into the detrusor muscle. We used a 12mm camera port just superior to the umbilicus and three 8mm robotic ports. A 12mm accessory port was also placed for additional assistance. A cecostomy tube was also placed robotically to manage the patient's neurogenic bowel. The ileovesicootomy stoma was created in the left lower quadrant by extending the left arm robotic port site.
RESULTS: The patient was admitted the day prior to the procedure for mechanical bowel prep. The next morning she was taken to the operating room for the procedure. Total operative time was 406 minutes. Anesthesia induction was 17 minutes, cystoscopy and botox injection was 10 minutes and port placement and laparoscopic dissection took 22 minutes. Total console time was 244 minutes and closure time was 14 minutes. The remaining 96 minutes was for patient positioning and preparation. A foley catheter was placed per her urethra temporarily to keep her bladder decompressed to aid in wound healing and was removed prior to discharge. She was started on a clear liquid diet on post-operative day #2 and advanced as tolerated. The patient was discharged home on post-operative day #4 with no surgical drainage tubes except for her urostomy. At 5-month follow-up her creatinine remains at her baseline of 0.9 and her ultrasound shows no hydronephrosis. She has no leakage per urethra.
CONCLUSIONS: Robotic assisted ileovesocostomy is technically feasible in the pediatric population. As experience increases with such techniques, these authors expect that robotic surgery can be utilized in more complex reconstruction and patients can experience the benefits that minimally invasive techniques offer. INTRODUCTION AND OBJECTIVES: Robotic partial nephrectomy (RPN) provides for nephron sparing and renal preservation with a minimally invasive approach. Though commonly utilized in adults for resection of renal masses, it is less commonly applied for tumors in children. To optimize outcomes in these patients, techniques from the adult setting were translated to the pediatric realm, with the goals of fostering bi-directional transfer of expertise and knowledge and of achieving safe and effective application of this surgical approach.
Source of Funding: None
